The biotechnological company Seattle Genetics is focused on researching and developing new monoclonal-antibody treatments which fight cancer cells by binding and targeting them. The company, is considered a leader in antibody-drug conjugates (ADCs) development and trials. Adcetris is Seattle Genetics’ flagship product has currently two patents and has been approved for use in over 50 countries. There is also a pipeline of ADCs that the company is researching for different types of cancers. Propriety technology is used to explore treatments for tumors and malignancies.
Clay Siegall is the co-founder and CEO of Seattle Genetics. Under his leadership, the company has been very successful. Siegall’s vision of creating a biotechnological company to explore effective cancer treatments has led to advanced breakthrough therapies. The company has received licenses with well-known drug companies like Pfizer, Roche, and Abbvie with Siegall’s direction. His entrepreneurial spirit has made a positive impact on the lives of many people. Through his monoclonal-antibody therapies, cancer patients have lived better. The treatments fight cancer cells without attacking healthy cells. As a result, patients may feel healthier and end up participating in more of the activities they enjoy.
More than 15,000,000 lymphoma patients have been treated with Adcetris. Clay Siegall believes that the treatment has the potential to be an integral part of Hodgkin Lymphoma therapy. Seagall plans to make investments with his pipeline of drugs, since early clinical trials have revealed them to be effective. These drugs stabilize in the blood stream and release toxic agents to tumor cells. Clay Seagall plans to continue researching new therapies using his innovative technological methods.
Seattle Genetics has a successful work environment where collaboration is encouraged. Clay Siegall wanted to start a company that was not only successful, but was compassionate and ethical. Teamwork and mutual respect is encouraged which leads to better results. Focused staff members can discover new breakthroughs and solve many unforeseen challenges.